Advertisement
Advertisement
TWST
Twist Bioscience Corporation Common Stock
95.86
USDSponsored
+8.41
+9.62%
Jul 21, 15:59 UTC -4
Closed
After-Market
95.00
-0.86
-0.90%
TWST Earnings Reports
Positive Surprise Ratio
TWST beat 18 of 31 last estimates.
58%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$116.77M
/-$0.50
Implied change from Q2 26 (Revenue/ EPS)
+5.47%
/-15.25%
Implied change from Q3 25 (Revenue/ EPS)
+21.56%
/+6.38%
Twist Bioscience Corporation Common Stock earnings per share and revenue
On May 04, 2026, TWST reported earnings of -0.59 USD per share (EPS) for Q2 26, missing the estimate of -0.48 USD, resulting in a -21.17% surprise. Revenue reached 110.72 million, compared to an expected 109.81 million, with a 0.82% difference. The market reacted with a -6.97% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.50 USD, with revenue projected to reach 116.77 million USD, implying an decrease of -15.25% EPS, and increase of 5.47% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jul 09, 2026 For Q2 26
Estimate
-$0.73
Actual
-$0.81
Surprise
-10.78%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were Twist Bioscience Corporation Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Twist Bioscience Corporation Common Stock reported EPS of -$0.59, missing estimates by -21.17%, and revenue of $110.72M, 0.82% above expectations.
How did the market react to Twist Bioscience Corporation Common Stock's Q2 2026 earnings?
The stock price moved down -6.97%, changed from $60.40 before the earnings release to $56.19 the day after.
When is Twist Bioscience Corporation Common Stock expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Twist Bioscience Corporation Common Stock's next earnings report?
Based on 11
analysts, Twist Bioscience Corporation Common Stock is expected to report EPS of -$0.50 and revenue of $116.77M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement